{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:18Z","timestamp":1791999498202,"version":"4.4.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) and multiple sclerosis (MS) are two CNS disorders affecting millions of people, for which no cure is available. AD is usually diagnosed in individuals age 65 and older and manifests with accumulation of beta amyloid in the brain. MS, a demyelinating disorder, is most commonly diagnosed in its relapsing-remitting (RRMS) form in young adults (age 20\u201340). The lack of success in a number of recent clinical trials of immune- or amyloid-targeting therapeutics emphasizes our incomplete understanding of their etiology and pathogenesis. Evidence is accumulating that infectious agents such as viruses may contribute either directly or indirectly. With the emerging recognition that demyelination plays a role in risk and progression of AD, we propose that MS and AD are connected by sharing a common environmental factor (a viral infection such as HSV-1) and pathology (demyelination). In the <jats:underline>v<\/jats:underline>iral <jats:underline>DE<\/jats:underline>myelinating <jats:underline>N<\/jats:underline>eurodegenerative <jats:underline>T<\/jats:underline>rigger (vDENT) model of AD and MS, the initial demyelinating viral (e.g., HSV-1) infection provokes the first episode of demyelination that occurs early in life, with subsequent virus reactivations\/demyelination and associated immune\/inflammatory attacks resulting in RRMS. The accumulating damage and\/or virus progression deeper into CNS leads to amyloid dysfunction, which, combined with the inherent age-related defects in remyelination, propensity for autoimmunity, and increased blood-brain barrier permeability, leads to the development of AD dementia later in life. Preventing or diminishing vDENT event(s) early in life, thus, may have a dual benefit of slowing down the progression of MS and reducing incidence of AD at an older age.<\/jats:p>","DOI":"10.3389\/fnagi.2023.1204852","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:44:30Z","timestamp":1686807870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Alzheimer\u2019s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)"],"prefix":"10.3389","volume":"15","author":[{"given":"Marina S.","family":"Boukhvalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Kastrukoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge C. G.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"Alzheimer\u2019s disease facts and figures.","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.623914","article-title":"Thalamic Injury and Cognition in Multiple Sclerosis","volume":"11","author":"Amin","year":"2020","journal-title":"Front Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2017.09.043","article-title":"The present and future of pharmacotherapy of Alzheimer\u2019s disease: a comprehensive review.","volume":"815","author":"Anand","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF00867354","article-title":"Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.","volume":"240","author":"Andersen","year":"1993","journal-title":"J. Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease.","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00790","article-title":"Hallmarks of aging: an autophagic perspective.","volume":"9","author":"Barbosa","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(98)00067-9","article-title":"Herpesviruses: a rationale for antiviral treatment in multiple sclerosis.","volume":"41","author":"Bergstrom","year":"1999","journal-title":"Antiviral Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1128\/JVI.01387-15","article-title":"Efficacy of the herpes simplex virus 2 (HSV-2) Glycoprotein D\/AS04 vaccine against genital HSV-2 and HSV-1 infection and disease in the cotton rat sigmodon hispidus model.","volume":"89","author":"Boukhvalova","year":"2015","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000473","article-title":"Bell\u2019s palsy and lip HSV-1 infection: importance of subcutaneous access.","volume":"8","author":"Boukhvalova","year":"2022","journal-title":"J. Transl. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e01161","DOI":"10.1128\/JVI.01161-19","article-title":"Herpes simplex virus 1 induces brain inflammation and multifocal demyelination in the cotton rat sigmodon hispidus.","volume":"94","author":"Boukhvalova","year":"2019","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biologicals.2009.02.017","article-title":"The cotton rat model of respiratory viral infections.","volume":"37","author":"Boukhvalova","year":"2009","journal-title":"Biologicals"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/2040206618770518","article-title":"Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.","volume":"26","author":"Boukhvalova","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-014-1356-1","article-title":"Are cases with tau pathology occurring in the absence of A\u03b2 deposits part of the AD-related pathological process?","volume":"128","author":"Braak","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","article-title":"The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease.","author":"Braak","year":"2015","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3233\/JAD-220287","article-title":"Potential involvement of varicella zoster virus in Alzheimer\u2019s disease via reactivation of quiescent herpes simplex virus type 1.","volume":"88","author":"Cairns","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2016.03.027","article-title":"Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer\u2019s disease.","volume":"43","author":"Couttas","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019.","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013989","article-title":"APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells.","volume":"5","author":"De Chiara","year":"2010","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice.","volume":"15","author":"De Chiara","year":"2019","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/msj.20239","article-title":"Current disease-modifying treatment of multiple sclerosis.","volume":"78","author":"Derwenskus","year":"2011","journal-title":"Mt. Sinai J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11357-022-00621-4","article-title":"Aging compromises oligodendrocyte precursor cell maturation and efficient remyelination in the monkey brain.","volume":"45","author":"Dimovasili","year":"2023","journal-title":"Geroscience"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00046","article-title":"Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders.","volume":"13","author":"Duarte","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B25","first-page":"S109","article-title":"Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack.","volume":"6","author":"Ferrante","year":"2000","journal-title":"J. Neurovirol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13365-012-0110-5","article-title":"Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.","volume":"18","author":"Ferr\u00f2","year":"2012","journal-title":"J. Neurovirol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/135245859500100203","article-title":"Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study.","volume":"1","author":"Haahr","year":"1995","journal-title":"Multiple Sclerosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000110945","article-title":"Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus?","volume":"11","author":"Haahr","year":"1992","journal-title":"Neuroepidemiology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00048","article-title":"Molecular mechanisms for herpes simplex virus type 1 pathogenesis in Alzheimer\u2019s disease.","volume":"10","author":"Harris","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","article-title":"Epidemiology of multiple sclerosis.","volume":"34","author":"Howard","year":"2016","journal-title":"Neurol. Clin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40265-021-01526-w","article-title":"Failed, interrupted, or inconclusive trials on neuroprotective and neuroregenerative treatment strategies in multiple sclerosis: update 2015-2020.","volume":"81","author":"Huntemann","year":"2021","journal-title":"Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1096\/fj.201700360","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: possible mechanisms and signposts.","volume":"31","author":"Itzhaki","year":"2017","journal-title":"FASEB J."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060679","article-title":"Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer\u2019s disease (AD); underwhelming evidence against.","volume":"9","author":"Itzhaki","year":"2021","journal-title":"Vaccines"},{"key":"B36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease.","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains.","volume":"33","author":"Jamieson","year":"1991","journal-title":"J. Med. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ana.410220113","article-title":"Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1.","volume":"22","author":"Kastrukoff","year":"1987","journal-title":"Ann. Neurol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/2042-4280-3-4","article-title":"The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).","volume":"3","author":"Kastrukoff","year":"2012","journal-title":"Herpesviridae"},{"key":"B40","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/00005072-199207000-00005","article-title":"Herpes simplex virus type I (HSV I)-induced multifocal central nervous system (CNS) demyelination in mice.","volume":"51","author":"Kastrukoff","year":"1992","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.apmr.2016.04.016","article-title":"Rehabilitation in multiple sclerosis: a systematic review of systematic reviews.","volume":"98","author":"Khan","year":"2017","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality.","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330582","article-title":"Multiple sclerosis mortality in New Zealand: a nationwide prospective study.","author":"Leadbetter","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000110248","article-title":"Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis.","volume":"10","author":"Lindeberg","year":"1991","journal-title":"Neuroepidemiology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","article-title":"Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.","volume":"88","author":"Lunde","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00868517","article-title":"Acyclovir treatment of relapsing-remitting multiple sclerosis.","volume":"243","author":"Lycke","year":"1996","journal-title":"J. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsptsci.9b00068","article-title":"Remyelination pharmacotherapy investigations highlight diverse mechanisms underlying multiple sclerosis progression.","volume":"2","author":"Melchor","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1097-1133","article-title":"Persistent infection with Theiler\u2019s virus leads to CNS autoimmunity via epitope spreading.","volume":"3","author":"Miller","year":"1997","journal-title":"Nat. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/jaut.2000.0489","article-title":"Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler\u2019s virus infection.","volume":"16","author":"Miller","year":"2001","journal-title":"J. Autoimmune"},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0197-4580(88)80013-7","article-title":"Effect of aging on the blood-brain barrier.","volume":"9","author":"Mooradian","year":"1988","journal-title":"Neurobiol. Aging."},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/13550281003739040","article-title":"Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes.","volume":"16","author":"Mori","year":"2010","journal-title":"J. Neurovirol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113945","article-title":"Alzheimer\u2019s disease beyond amyloid: can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?","volume":"177","author":"Mullane","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1600-0404.1998.tb00632.x","article-title":"The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?","volume":"97","author":"Munch","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes.","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00808-z","article-title":"Global synergistic actions to improve brain health for human development.","author":"Owolabi","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/ana.410360709","article-title":"Influence of infection on exacerbations of multiple sclerosis","volume":"36","author":"Panitch","year":"1994","journal-title":"Ann. Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/aoms.2018.76863","article-title":"The role of myelin damage in Alzheimer\u2019s disease pathology.","volume":"16","author":"Papu\u0107","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.neurobiolaging.2010.06.009","article-title":"HSV-1 promotes Ca2+ -mediated APP phosphorylation and Abeta accumulation in rat cortical neurons.","volume":"32","author":"Piacentini","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B59","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.it.2023.02.002","article-title":"Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity.","volume":"44","author":"Ransohoff","year":"2023","journal-title":"Trends Immunol."},{"key":"B60","first-page":"2399","article-title":"Herpes simplex viruses and their replication, Chapter 72","author":"Roizman","year":"2001","journal-title":"Fields virology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40259-020-00435-w","article-title":"Failed, interrupted, or inconclusive trials on immunomodulatory treatment strategies in multiple sclerosis: update 2015-2020.","volume":"34","author":"Rolfes","year":"2020","journal-title":"BioDrugs."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639369","article-title":"Common peripheral immunity mechanisms in multiple sclerosis and Alzheimer\u2019s disease.","volume":"12","author":"Rossi","year":"2021","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease.","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm1297-1394","article-title":"Association of human herpesvirus type 6 with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.","volume":"3","author":"Soldan","year":"1997","journal-title":"Nat. Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2015.06.004","article-title":"Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis.","volume":"355","author":"Sugiyama","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","article-title":"Cognition in multiple sclerosis: state of the field and priorities for the future.","volume":"90","author":"Sumowski","year":"2018","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nrl.2017.07.002","article-title":"Experimental models of demyelination and remyelination.","volume":"35","author":"Torre-Fuentes","year":"2020","journal-title":"Neurologia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in Taiwan.","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy.","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/187152712801661220","article-title":"Viruses and multiple sclerosis.","volume":"11","author":"Virtanen","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data.","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review.","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections.","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1.","volume":"16","author":"Wozniak","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2020.10.044","article-title":"The association between herpes simplex virus type 1 infection and Alzheimer\u2019s disease.","author":"Wu","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease.","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update.","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-2008-14301","article-title":"Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1.","volume":"14","author":"Zambrano","year":"2008","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1204852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:44:35Z","timestamp":1686807875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1204852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":79,"alternative-id":["10.3389\/fnagi.2023.1204852"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1204852","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"article-number":"1204852"}}